Methods for Improving Pancreatic Islet Transplantation

Information

  • Research Project
  • 7404640
  • ApplicationId
    7404640
  • Core Project Number
    R42DK064424
  • Full Project Number
    2R42DK064424-02A2
  • Serial Number
    64424
  • FOA Number
    PA-07-81
  • Sub Project Id
  • Project Start Date
    3/1/2003 - 22 years ago
  • Project End Date
    3/31/2010 - 15 years ago
  • Program Officer Name
    ARREAZA-RUBIN, GUILLERMO
  • Budget Start Date
    4/7/2008 - 17 years ago
  • Budget End Date
    3/31/2009 - 16 years ago
  • Fiscal Year
    2008
  • Support Year
    2
  • Suffix
    A2
  • Award Notice Date
    4/7/2008 - 17 years ago
Organizations

Methods for Improving Pancreatic Islet Transplantation

[unreadable] DESCRIPTION (provided by applicant): Diabetes is a serious disease affecting over 1 million people in the United States. The standard treatment, injection of insulin, is not sufficient to control blood glucose in many patients and leads to complications such as kidney failure, limb amputations and blindness. Recently a new experimental therapy has shown promise of cure for this disease. The therapy consists of isolating clusters of the insulin secreting cells, called islets from cadaver pancreases and transplanting them into diabetic patients. While the results of these experimental transplants have been promising, it has been difficult to keep the islets alive once they have been isolated from the pancreas. Recently it has been shown in an animal model of diabetes, that culturing islets in a new type of bioreactor system invented at NASA, can significantly improve the survival of islets outside the body and improve the success of islet transplantation. The goal of this project is to adapt this culture system to culture human islets so that they will improve the outcome of islet transplantation to treat diabetes. [unreadable] [unreadable] Project Narrative: Pancreatic islet transplantation holds great promise for a cure for type 1 diabetes. We have experimental evidence that culturing islets in the Rotary Cell Culture System can improve the survival and function of islets after transplantation. The goal of this proposal is to verify the previous results in human patients so that this technology can be used to improve this promising therapy for diabetes. [unreadable] [unreadable] [unreadable]

IC Name
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
  • Activity
    R42
  • Administering IC
    DK
  • Application Type
    2
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    368254
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    847
  • Ed Inst. Type
  • Funding ICs
    NIDDK:368254\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    SYNTHECON, INC.
  • Organization Department
  • Organization DUNS
    809505225
  • Organization City
    HOUSTON
  • Organization State
    TX
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    77054
  • Organization District
    UNITED STATES